Our study aim was to evaluate the performance of the automated Sysmex HISCL® SARS-CoV-2 antigen assay against RT-PCR. We tested 277 remnant frozen nasopharyngeal swab samples, stored in universal transport… Click to show full abstract
Our study aim was to evaluate the performance of the automated Sysmex HISCL® SARS-CoV-2 antigen assay against RT-PCR. We tested 277 remnant frozen nasopharyngeal swab samples, stored in universal transport medium (UTM), yielding a sensitivity of 94.9% against historical RT-PCR results with cycle threshold (Ct) <30, and a sensitivity of 76.7% for Ct<35, and specificity of 100% (all Ct values) confirming compatibility of UTM-diluted samples with the assay system. Thereafter, we prospectively collected 141 nasopharyngeal swab samples in UTM from healthcare workers and 1369 paired swabs (400 UTM; 969 dry) from individuals at a public health testing centre, with the first swab (UTM) reserved for RT-PCR, yielding a positivity rate of 4.6%. HISCL assay performance using UTM swabs was superior to dry swabs, with a sensitivity of 100% (95%CI 71.5-100%) at Ct<30 versus 92.3% (95%CI 81.5 - 97.9%), and a specificity of 99.3% (95%CI 98.1-99.89) against 83.3% (95%CI 80.7 - 85.6%). We conclude that this antigen assay is suitable for high throughput facilities where the primary indication for testing is to rule out infection with low RT-PCR Ct values (proxy for high viral loads) to curb viral spread. This article is protected by copyright. All rights reserved.
               
Click one of the above tabs to view related content.